In the News
Shire to combine with Baxalta in £22bn deal
Graham Watson
12th January 2016
More merger activity in the pharmaceutical sector as Shire and Baxalta confirm their £22billion merger, creating a giant market leader in the treatment of rare diseases.
You might also like
Diseconomies of Scale
Study Notes
Horizontal Integration - Pure Gym buys LA Fitness
30th May 2015
Three-O2 Merger Plans Under Scrutiny
5th February 2016
Fitbit acquires Pebble IP as Pebble Closes Down
8th December 2016
Watersones buys Foyles in bid to counter Amazon threat
7th September 2018
Marginal Cost Examples
Topic Videos
Why is Tesco so profitable?
Study Notes
Economies of Scale at Papa Johns
15th March 2024